- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 12: Patient Awareness About Clinical Pathways
Robert Dubois, MD, PhD, shares findings from their recently published study in The American Journal of Managed Care, which showed that patients do not know they are being treated on predetermined pathways.
“How aware are patients about their clinician using or treating them on a clinical pathway? Is there awareness among the patient population of any financial incentives that might be involved in the process?” Surabhi Dangi-Garimella, PhD, asked the panelists.
Robert Dubois, MD, PhD, believes that there is minimal awareness among patients—as they discovered from a recent study that was published in The American Journal of Managed Care—and that this is both surprising and disconcerting.
The least transparent thing for patients is the financial incentives attached to pathway compliance. “Certainly, in the world of fee-for-service medicine there were concerns that patients may be receiving more care than they absolutely need, but as we move to a world where payments are going to be fixed, now there’s a concern that there could be some sort of underuse,” added Dr Dubois.
As such, Dr Dubois believes that moving forward there should be 2 things that are made clear to patients. First, that there are pathways in use and that there are ways around these pathways if needed. And second, there are financial incentives to adherence and that if a doctor falls below a certain percentage there may be financial consequences.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
September 17th 2025Although children living with myopia taking atropine did experience an increased incidence of cataracts, glaucoma, or maculopathy, it is unclear if this risk was confounded by myopia severity.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
